- Home
- / Merrimack Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Merrimack Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$15.1
2024-05-28
Market Capitalization
$223.7 M
2024-05-28
Revenue
$144.3 M
FY, 2016
CreditSafe Score
?
Score changed on Oct 14, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48.9M | 47.8M | 102.8M | 89.3M | 144.3M | |||||||
| Revenue growth, % | 115.0% | -13.1% | 61.6% | |||||||||
| Cost of goods sold | 46.0K | 6.9M | ||||||||||
| Gross profit | 89.2M | 137.4M | ||||||||||
| Gross profit margin, % | 99.9% | 95.2% | ||||||||||
| General and administrative expense | 15.8M | 21.2M | 30.5M | 57.8M | 80.7M | 28.5M | 15.6M | 16.2M | 5.0M | 2.6M | 2.2M | 2.2M |
| Operating expense total | 141.7M | 168.3M | 169.0M | 218.8M | 247.5M | 105.3M | 65.6M | 27.3M | 5.0M | 2.2M | ||
| EBIT | (92.7M) | (120.5M) | (66.3M) | (129.6M) | (110.1M) | (95.8M) | (65.6M) | (22.4M) | (2.9M) | (2.5M) | (1.7M) | (2.0M) |
| EBIT margin, % | -189.6% | -252.2% | -64.5% | -145.2% | -76.3% | |||||||
| Interest income | 184.0K | 166.0K | 114.0K | 99.0K | 276.0K | 895.0K | 1.3M | 777.0K | 50.0K | 20.0K | 188.0K | 868.0K |
| Interest expense | 553.0K | 10.9M | 18.2M | 2.9M | ||||||||
| Pre tax profit | (118.4M) | (68.5M) | (22.7M) | (3.0M) | (2.5M) | (1.5M) | (1.2M) | |||||
| Income tax expense | (42.4M) | (7.7M) | (1.5M) | 14.0K | 3.0K | 3.0K | 12.0K | |||||
| Net Income | (91.3M) | (130.9M) | (83.3M) | (148.0M) | (151.7M) | 472.0M | (40.5M) | (17.3M) | (3.0M) | (2.5M) | (1.5M) | (1.2M) |
| EPS | (0.1) |